The following information was taken from the 2015 annual report of Bristol-Myers Squibb, a world-leading drug company (dollars in millions).

Prepare an income statement, balance sheet, and statement of cash flows, and comment on the financial performance and condition of the company. The company€™s year-end is December 31.

Transcribed Image Text:

Cost of goods sold Net cash from operations Accounts receivable Income tax expense Net cash from financing Shareholders' equity Net cash from investing $ 3,909 Cash and equivalents Short-term borrowings Accounts payable Long-term liabilities Net sales Property, plant, and equipment Other current assets Other current liabilities Marketing, selling, and adm. expense Accrued payables $ 2,385 1,832 4,299 139 1,565 9,307 16,560 4,412 446 (3,351) 14,424 (1,572) 5,920 1,846 2,230 4,841 4,083 Research and dev. expense Other noncurrent assets Other expenses Short-term investments 16,921 (187) 1,885